#USA #Raleigh #Lallemand #NurtureBio #infant gut health

NurtureBio and Lallemand Join Forces for Infant Gut Health

In an exciting development for maternal and child wellness, NurtureBio has officially announced its collaboration with Lallemand Health Solutions. This partnership is centered around the creation of a groundbreaking synbiotic supplement designed specifically for infants and toddlers. Set to launch in June 2026, this new product promises to harness the power of breast milk's natural components to support infant gut health during the crucial early stages of life.

Understanding the Synbiotic Innovation

The highlight of this collaboration is the new supplement that combines human milk oligosaccharides (HMOs) with clinically validated probiotic strains. HMOs, which are found abundantly in breast milk, play a significant role in shaping the gut microbiome of infants, thus supporting both digestive and immune health. NurtureBio aims to capitalize on the scientific insights gained from extensive research into breast milk and the microbiome, translating them into accessible solutions for families.

Stuart Smith, the founder of NurtureBio, articulated the challenge many parents face with their child's digestive health. He noted, "Parents are often told that common digestive issues are something their child will simply 'grow out of,' even when those issues are disrupting daily life." With this new synbiotic blend, NurtureBio aims to reassure parents that effective support is available, blending cutting-edge microbiome science with familiarity from the biology behind human milk.

The Role of Lallemand Health Solutions

Lallemand Health Solutions brings a wealth of expertise in probiotic strain development. Their experience in creating clinically documented probiotics complements NurtureBio's focus on innovative infant nutrition solutions. Reginald Wang, the business manager at Lallemand, expressed enthusiasm for the partnership: "Partnering with NurtureBio is a privilege to have a platform where our extensive know-how in microbiome research is translated to a product that consumers can benefit from."

This collaboration is not just about creating another product; it seeks to address real-life challenges faced by parents, backed by solid scientific principles. The combined forces of these two companies are geared towards enhancing infant health outcomes by improving gut health right from the start.

Scientifically Backed Formulation

Recent scientific findings emphasize the significance of the infant's gut microbiome in their overall development. The specific probiotic strains included in NurtureBio's synbiotic blend - Bifidobacterium infantis Rosell®–33 and Bifidobacterium bifidum Rosell®-71 - are chosen for their proven benefits in infant digestive health. The formula aims to bridge the nutritional gap between breast milk and artificial feeding options, ensuring that infants receive essential nutrients for healthy growth.

NurtureBio plans to offer its synbiotic product directly through their website, making it easily accessible for families seeking science-driven health solutions. This move not only reflects their commitment to public health but also aligns with their broader mission to democratize access to advanced nutritional products for infants.

A Focus on Research and Development

Since its inception in 2024, NurtureBio has actively collaborated with leading academic institutions, including the University of Cincinnati College of Medicine. They are dedicated to advancing clinical studies focused on infant gut health and breast milk composition. This research-first approach demonstrates their commitment to transparency and quality, aiming to foster trust among families using their products.

The relationship between diet and early health outcomes cannot be overstated, and ventures like this one highlight a promising future for infant care. The emerging combination of HMO and probiotic science positions NurtureBio and Lallemand at the forefront of a new wave of infant nutrition solutions grounded in solid research.

Conclusion

The collaboration between NurtureBio and Lallemand Health Solutions represents a significant advancement in promoting infant health through innovative, science-backed nutrition. As this partnership unfolds, it holds the potential to improve quality of life for families by addressing crucial aspects of gut health in infants, bridging the gap between scientific innovation and practical application for better health.

For more information about the upcoming product, visit NurtureBio's website to stay updated on its launch and benefits.